BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19708940)

  • 1. Duodeno-pancreatic neuroendocrine tumours.
    Peros G; Sakorafas GH; Konstantoudakis G; Giannopoulos GA; Petropoulou K; Parasi A
    Eur J Cancer Care (Engl); 2010 May; 19(3):393-402. PubMed ID: 19708940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
    Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
    Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
    Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
    Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
    Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
    Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
    Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
    Metz DC
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour markers in neuroendocrine tumours.
    Oberg K; Janson ET; Eriksson B
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The coexistence of 2 different neuroendocrine tumors of the upper gastrointestinal tract and pancreas].
    Reusch J; Keck AM; Link KH; Mohr HH
    Dtsch Med Wochenschr; 1998 Dec; 123(49):1472-7. PubMed ID: 9861888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duodenal gastrointestinal stromal tumor with epithelioid and neural features mimicking a primary pancreas head neuroendocrine tumor.
    Slavik T; du Plessis J; Sparaco A; van der Merwe SW
    Pancreas; 2014 Apr; 43(3):482-3. PubMed ID: 24622084
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
    Plöckinger U; Wiedenmann B
    Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-operative procedures to localize endocrine tumours of the pancreas and duodenum.
    Norton JA
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S195-7. PubMed ID: 10604129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of neuroendocrine tumours of the pancreas].
    Farkas G
    Magy Onkol; 2003; 47(4):345-7. PubMed ID: 14716428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
    Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
    Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-producing pancreatic endocrine tumour. Histological, ultrastructural and immunohistochemical study of a case.
    Kanavaros P; Hoang C; Le Bodic MF; Polivka M; Hautefeuille P
    Histol Histopathol; 1990 Jul; 5(3):325-8. PubMed ID: 1966880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine tumours of the pancreas.
    Oberg K; Eriksson B
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):753-81. PubMed ID: 16253899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcitonemia revealing a somatostatinoma.
    Do Cao C; Mekinian A; Ladsous M; Aubert S; D'Herbomez M; Pattou F; Bourdelle-Hego MF; Wémeau JL
    Ann Endocrinol (Paris); 2010 Dec; 71(6):553-7. PubMed ID: 20817146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.